Wide price variation in hospital prices for the care that they render-up to a 2.7-fold difference-is driven by the hospital's market leverage, according to a new report by the New York State Health Foundation (NYSHealth).
Wide price variation in hospital prices for the care that they render—up to a 2.7-fold difference—is driven by the hospital’s market leverage, according to a new report by the New York State Health Foundation (NYSHealth).
The study was commissioned by NYSHealth in an attempt to understand the various factors that influence the rapidly rising healthcare costs in the state of New York, which in turn translate into rising health insurance premiums. The study team delved deep into understanding hospital contracting practices, reimbursement methods, and hospital prices in the state by using data provided by 9 private commercial insurers for 107 hospitals in 3 regions in New York: Downstate, Albany, and Buffalo. While the team analyzed private commercial prices only, the influence of revenue from a public payer on a hospital’s revenue was considered.
The following are key findings of the report:
After considering these findings, the authors of the report have made certain policy recommendations to help amend the observed discrepancy in hospital prices:
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
HMO and EPO Insurance Plans More Likely to Promote Use of Biosimilars
November 21st 2023Health plan type highly influences the likelihood of biosimilar uptake, with low-flexibility insurance plans more likely to have patients who either switched to a biosimilar or were initiated on a biosimilar.
Read More
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
Therapists’ Perspectives on Access to Telemental Health Among Medicaid-Enrolled Youth
November 10th 2023This qualitative study elucidates therapists’ perspectives on barriers to and facilitators of access to telemental health among Medicaid-enrolled youth served by a large safety-net organization.
Read More